David A. Siegel Arvinas, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Arvinas, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 282,600 shares of ARVN stock, worth $5.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

282,600

Previous 227,600 24.17%

Holding current value

$5.02 Million

Previous $5.61 Million 3.35%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.83 - $28.04 $980,649 - $1.54 Million	55,000 Added 24.17%	282,600 $5.42 Million
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $4.4 Million - $6.08 Million	185,900 Added 445.8%	227,600 $5.61 Million
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $139,422 - $230,280	-5,700 Reduced 12.03%	41,700 $1.11 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $1.72 Million - $2.48 Million	47,400 New	47,400 $1.96 Million
Q3 2023 Nov 14, 2023	SELL	$19.64 - $28.21 $1.07 Million - $1.54 Million	-54,600 Reduced 73.19%	20,000 $392,000
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $1.16 Million - $1.68 Million	53,600 Added 255.24%	74,600 $1.85 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $549,150 - $782,460	21,000 New	21,000 $573,000
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $176,449 - $363,776	4,900 New	4,900 $206,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $13.1 Million - $17.7 Million	-216,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $7.85 Million - $11.5 Million	-119,200 Reduced 35.47%	216,900 $17.8 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $1.71 Million - $2.52 Million	23,394 Added 7.48%	336,100 $27.6 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $1.44 Million - $2.01 Million	23,806 Added 8.24%	312,706 $24.1 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $215,303 - $338,069	3,700 Added 1.3%	288,900 $19.1 Million
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $2.43 Million - $10.2 Million	-120,500 Reduced 29.7%	285,200 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $1.23 Million - $1.94 Million	53,400 Added 15.16%	405,700 $9.58 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $7.41 Million - $14.1 Million	247,900 Added 237.45%	352,300 $11.8 Million
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $2.51 Million - $4.14 Million	76,000 Added 267.61%	104,400 $4.21 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $437,076 - $1.26 Million	28,400 New	28,400 $1.17 Million

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

70.9M

Call Options Held

1.52M

Put Options Held

346K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $945M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account